Global Spinal Muscular Atrophy (SMA) Pipeline Review 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Spinal Muscular Atrophy (SMA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Spinal Muscular Atrophy (SMA) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Spinal Muscular Atrophy (SMA) Overview
3. Therapeutics Development
4. Pipeline Products for Spinal Muscular Atrophy (SMA) - Overview
5. Pipeline Products for Spinal Muscular Atrophy (SMA) - Comparative Analysis
6. Spinal Muscular Atrophy (SMA) - Therapeutics under Development by Companies
7. Spinal Muscular Atrophy (SMA) - Therapeutics under Investigation by Universities/Institutes
8. Spinal Muscular Atrophy (SMA) Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Spinal Muscular Atrophy (SMA) - Products under Development by Companies
13. Spinal Muscular Atrophy (SMA) - Products under Investigation by Universities/Institutes
14. Spinal Muscular Atrophy (SMA) - Companies Involved in Therapeutics Development

• Astellas Pharma Inc.
• AveXis, Inc.
• Bioblast Pharma Ltd.
• Cytokinetics, Inc.
• F. Hoffmann-La Roche Ltd.
• Genethon
• Genzyme Corporation
• GMP-Orphan SAS
• Ionis Pharmaceuticals, Inc.
• Longevity Biotech, Inc
• Neurodyn Inc.
• Neurotune AG
• Novartis AG
• Sarepta Therapeutics, Inc.
• Voyager Therapeutics, Inc.
• Vybion, Inc.
• WAVE Life Sciences Ltd.

For more information visit http://www.researchandmarkets.com/research/s257rm/spinal_muscular